Xing-chen Peng
West China Hospital & State Key Laboratory Of Biotherapy
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Randomized, double-blind phase III trial of a dexamethasone-free regimen for managing highly emetogenic chemotherapy-induced nausea and vomiting.
Journal: International journal of cancer
Published: January 31, 2025
Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma.
Journal: Signal transduction and targeted therapy
Published: October 11, 2024
Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial.
Journal: Nature communications
Published: August 03, 2024
Lactate dehydrogenase as promising marker for prognosis of brain metastasis.
Journal: Journal of neuro-oncology
Published: May 05, 2022
Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial.
Journal: Translational lung cancer research
Published: February 24, 2022
Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer.
Journal: Medical oncology (Northwood, London, England)
Published: May 07, 2015
The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.
Journal: Psychoneuroendocrinology
Published: August 18, 2014
Plasmid-encoding vasostatin inhibited the growth and metastasis of human hepatocellular carcinoma cells.
Journal: Molecular and cellular biochemistry
Published: February 03, 2014
Last Updated: 09/26/2026